2012 Annual Meeting | International Colloquium
12:00 PM - 12:05 PM |
Introduction
Massimo Pandolfo, MD, FAAN |
|
12:00 PM - 02:00 PM |
Break
|
|
12:05 PM - 12:30 PM |
How to Optimize Epilepsy Care in a Resource Limited Setting
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN |
|
12:30 PM - 12:55 PM |
Training Neurologists for Sub Saharan Africa: An Ethiopian Example
James H. Bower, MD, MSc, FAAN |
|
12:55 PM - 01:15 PM |
Risk Factors and Prevalence For Dementia and Alzheimer’s Disease in Pichincha, Ecuador
Patricio S. Espinosa, MD, MPH, FAAN |
|
01:15 PM - 01:35 PM |
NIH Programs to Support International Training and Collaboration
Walter J. Koroshetz, MD, FAAN |
|
01:35 PM - 01:55 PM |
Getting Fellowship Training in the US-Where and How to Apply
Richard S. Isaacson, MD, FAAN |
|
01:55 PM - 02:00 PM |
Conclusion
|
Massimo Pandolfo, MD, FAAN | Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities. |
James H. Bower, MD, MSc, FAAN | The institution of Dr. Bower has received research support from Abbvie. |
Richard S. Isaacson, MD, FAAN | Dr. Isaacson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Isaacson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care. |
Walter J. Koroshetz, MD, FAAN | Dr. Koroshetz has nothing to disclose. |
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN | An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities. |
Patricio S. Espinosa, MD, MPH, FAAN | Dr. Espinosa has nothing to disclose. |